A new low-concentration preparation for mydriasis and cycloplegia. 1980

A R Forman

This study was designed to evaluate a low-concentration, cycloplegic-mydriatic mixture of phenylephrine and tropicamide in a routine office examination. No clinically significant difference in pupillary dilation was found between the usual instillation of the standard, commercially available phenylephrine 10% and tropicamide 1% drops and the prepared, low-concentration solution. Pupillary dilation was well maintained during direct and indirect ophthalmoscopy and retinoscopy. This solution is easily prepared from readily available drugs, and is simply delivered to the eye using a standard eye dropper. The safety and effectiveness of this low-concentration mixture of phenylephrine and tropicamide make it strongly recommended for routine use.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009184 Mydriatics Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics. Cycloplegic,Cycloplegics,Mydriatic,Mydriatic Effect,Mydriatic Effects,Effect, Mydriatic,Effects, Mydriatic
D010656 Phenylephrine An alpha-1 adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent. (R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol,Metaoxedrin,Metasympatol,Mezaton,Neo-Synephrine,Neosynephrine,Phenylephrine Hydrochloride,Phenylephrine Tannate,Neo Synephrine,Tannate, Phenylephrine
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005128 Eye Diseases Diseases affecting the eye. Eye Disorders,Eye Disease,Eye Disorder
D005260 Female Females

Related Publications

A R Forman
April 1963, The British journal of ophthalmology,
A R Forman
January 2023, Arquivos brasileiros de oftalmologia,
A R Forman
January 1978, Archives of ophthalmology (Chicago, Ill. : 1960),
A R Forman
January 2023, Arquivos brasileiros de oftalmologia,
A R Forman
August 1992, Klinische Monatsblatter fur Augenheilkunde,
A R Forman
May 1979, American journal of ophthalmology,
A R Forman
December 1978, American journal of ophthalmology,
A R Forman
March 1999, Investigative ophthalmology & visual science,
A R Forman
February 1974, British journal of clinical pharmacology,
A R Forman
January 1990, Journal francais d'ophtalmologie,
Copied contents to your clipboard!